AMB-FUBINACA
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate
|
|
| Clinical data | |
| Legal status |
|
| Identifiers | |
| CAS Number | 1715016-76-4 |
| ChemSpider | 32055540 |
| Chemical data | |
| Formula | C21H22FN3O3 |
| Molar mass | 383.41 g/mol |
|
|
|
AMB-FUBINACA (also known as FUB-AMB) is an indazole-based synthetic cannabinoid that is presumed to be an agonist of the CB1 receptor and has been sold online as a designer drug.[1]
Legal status[edit]
The state of Louisiana banned AMB-FUBINACA through an emergency rule after it was detected in a synthetic cannabis product called "Train Wreck 2" which had been linked to adverse events and seizures on 3 June 2014.[2]
Sweden's public health agency suggested classifying AMB-FUBINACA as hazardous substance on November 10, 2014.[3]
See also[edit]
References[edit]
- ^ "FUB-AMB". Cayman Chemical. Retrieved 21 July 2015.
- ^ "DHH Adds Two New Synthetic Marijuana Compounds to Banned List". Louisiana Department of Health and Hospitals. 3 June 2014. Retrieved 21 July 2015.
- ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 21 July 2015.
 |
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
